Showing results (361-370 of 747) with videos related to
Sort By:
Pageof 75
FEBS Letters|November 24, 2015
Specific mutations in mammalian P4-ATPase ATP8A2 catalytic subunit entail differential glycosylation of the accessory CDC50A subunitAnna L Vestergaard, Stine A Mikkelsen, Jonathan A Coleman, et al.Tuberculosis (Edinburgh, Scotland)|September 20, 2008
A comparison of IFNgamma detection methods used in tuberculosis vaccine trialsNatalie E R Beveridge, Helen A Fletcher, Jane Hughes, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2025
BCG induced innate immune response heterogeneity and susceptibility to pediatric tuberculosisChristine Anterasian, Anele Gela, Temwa-Dango Mwambene, et al.Plos Pathogens|July 14, 2016
A Quantitative Analysis of Complexity of Human Pathogen-Specific CD4 T Cell Responses in Healthy M. tuberculosis Infected South AfricansCecilia S Lindestam Arlehamn, Denise M McKinney, Chelsea Carpenter, et al.AIDS (London, England)|May 24, 2022
Isoniazid preventive therapy and tuberculosis transcriptional signatures in people with HIVEthan D Valinetz, Daniel Matemo, Jill K Gersh, et al.Clinical Immunology (Orlando, Fla.)|November 11, 2008
Significantly skewed memory CD8+ T cell subsets in HIV-1 infected infants during the first year of lifeNazma Mansoor, Brian Abel, Thomas J Scriba, et al.Immunogenetics|February 9, 2013
A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general populationDenise M McKinney, Scott Southwood, Denise Hinz, et al.Scientific Reports|May 13, 2022
Non-volatile organic compounds in exhaled breath particles correspond to active tuberculosisDapeng Chen, Noella A Bryden, Wayne A Bryden, et al.American Journal of Respiratory and Critical Care Medicine|November 9, 2021
Molecular Detection of Airborne Mycobacterium tuberculosis in South African High SchoolsErick W Bunyasi, Keren Middelkoop, Anastasia Koch, et al.Clinical and Vaccine Immunology : CVI|May 16, 2014
Process of assay selection and optimization for the study of case and control samples from a phase IIb efficacy trial of a candidate tuberculosis vaccine, MVA85AStephanie A Harris, Iman Satti, Magali Matsumiya, et al.Pageof 75